Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $33.48 | $42.60 | -21.40% | 83.70x | 7.79x | 8.94x | 3.84x | 0.29x | $46.73M | 2.74% | $450.12M | 8.86 | $1.71B | 59.01 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $330.87 | $81.66 | 305.18% | 138.44x | 44.35x | 11.67x | 55.60x | 1.66x | $465.38M | 1.07% | $789.18M | 6.02 | $45.19B | 71.57 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.32 | $19.38 | -51.91% | 6.66x | 16.46x | 4.84x | 3.54x | 0.27x | -$1.99M | -0.39% | $154.66M | 2.80 | $547.99M | 5.52 | ||
| ADMA | ADMA BIOLOGICS INC | $9.01 | $11.16 | -19.25% | 14.53x | 9.76x | 4.21x | 4.50x | 0.40x | $27.82M | 1.30% | $477.32M | 2.00 | $2.13B | 10.77 | ||
| CORT | CORCEPT THERAPEUTICS INC | $40.31 | $26.42 | 52.59% | 42.43x | 48.79x | 5.50x | 6.62x | 0.66x | $141.79M | 3.39% | $647.81M | 6.24 | $4.17B | 92.32 | ||
| ABEO | ABEONA THERAPEUTICS INC | $4.48 | $18.40 | -75.65% | 3.34x | -69.89x | 40.73x | 1.61x | 0.14x | -$84.30M | -35.54% | $159.22M | 3.01 | $202.11M | 2.57 | ||
| HALO | HALOZYME THERAPEUTICS INC | $64.63 | $69.14 | -6.53% | 24.48x | 7.90x | 5.55x | 156.26x | 0.41x | $644.59M | 8.32% | $48.81M | 0.41 | $9.63B | 16.81 | ||
| KRYS | KRYSTAL BIOTECH INC | $258.32 | $107.79 | 139.65% | 36.49x | 32.82x | 19.21x | 6.19x | 1.29x | $189.35M | 2.53% | $1.22B | 42.14 | $7.06B | 36.04 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.41 | $4.29 | 2.81% | 20.05x | 14.66x | 2.70x | 4.61x | 0.49x | $13.21M | 3.79% | $76.53M | 0.97 | $291.18M | 14.82 | ||
| RPRX | ROYALTY PHARMA PLC | $47.97 | $41.04 | 16.87% | 26.80x | 9.28x | 8.67x | 2.85x | 0.53x | $2.22B | 10.76% | $9.71B | 22.60 | $36.00B | 33.38 | ||
| VCEL | VERICEL CORP | $32.17 | $8.24 | 290.62% | 97.48x | 62.30x | 5.86x | 4.60x | 1.73x | $24.75M | 1.53% | $354.64M | 7.05 | $1.63B | 46.68 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $40.23 | $4.93 | 715.91% | 223.50x | -33.89x | 5.06x | 13.89x | 3.52x | $45.01M | 0.89% | $370.15M | 2.93 | $5.15B | 73.57 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $28.01 | $36.24 | -22.71% | 10.15x | 7.73x | 1.85x | 1.86x | 0.46x | $347.89M | 21.60% | $870.22M | 15.14 | $1.03B | 4.04 | ||
| MNKD | MANNKIND CORP | $2.45 | $1.08 | 127.09% | 122.50x | 45.97x | 2.15x | -14.79x | 0.87x | $13.69M | 1.84% | -$51.02M | -0.17 | $1.28B | 24.28 | ||
| TECH | BIO-TECHNE CORP | $52.26 | $15.35 | 240.44% | 100.50x | 25.78x | 6.70x | 4.07x | 1.44x | $223.02M | 2.74% | $2.01B | 12.90 | $8.35B | 36.90 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.49 | $45.48 | 24.20% | 31.04x | 12.08x | 3.36x | 1.78x | 0.55x | $724.96M | 6.69% | $6.09B | 31.74 | $10.15B | 17.72 | ||
| EXEL | EXELIXIS INC | $42.89 | $34.16 | 25.55% | 14.89x | 13.67x | 5.02x | 5.15x | 0.80x | $875.84M | 7.52% | $2.16B | 7.96 | $10.83B | 10.89 | ||
| VCYT | VERACYTE INC | $32.21 | $11.79 | 173.22% | 38.35x | 27.84x | 4.89x | 1.95x | 1.54x | $126.63M | 5.00% | $1.31B | 16.67 | $2.23B | 24.13 | ||
| XOMA | XOMA ROYALTY CORP | $31.37 | $14.31 | 119.14% | 20.50x | 99.78x | 7.27x | 4.45x | 1.80x | -$1.83M | -0.48% | $83.94M | 6.95 | $416.69M | 12.01 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $772.64 | $427.47 | 80.75% | 17.94x | 16.53x | 5.63x | 2.61x | 1.38x | $4.08B | 5.05% | $31.26B | 298.82 | $81.27B | 13.97 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.76 | $13.70 | 80.76% | 14.15x | 12.82x | 5.14x | 3.17x | 2.03x | $208.61M | 6.89% | $954.27M | 7.80 | $2.32B | 7.20 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $446.54 | $173.62 | 157.19% | 28.88x | 23.03x | 9.51x | 6.08x | 1.72x | $3.19B | 2.80% | $18.67B | 73.00 | $110.20B | 22.65 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $199.65 | $76.14 | 162.21% | 31.00x | 23.51x | 14.40x | 3.91x | 1.67x | $48.09M | 1.25% | $1.02B | 52.60 | $4.26B | 21.35 | ||
| UTHR | UNITED THERAPEUTICS CORP | $592.98 | $236.00 | 151.27% | 19.68x | 19.85x | 8.25x | 3.66x | 2.82x | $1.04B | 3.96% | $7.10B | 160.19 | $24.43B | 13.43 | ||
| INCY | INCYTE CORP | $94.12 | $67.41 | 39.61% | 14.28x | 12.29x | 3.57x | 3.62x | 1.03x | $1.35B | 7.37% | $5.17B | 26.47 | $15.67B | 8.90 | ||
| CRMD | CORMEDIX INC | $6.79 | $12.33 | -44.91% | 3.02x | 4.99x | 1.57x | 1.32x | 18.35x | $172.79M | 35.33% | $405.31M | 5.63 | $540.83M | 3.23 | ||
| MDXG | MIMEDX GROUP INC | $3.95 | $1.86 | 112.49% | 11.97x | 34.17x | 1.39x | 2.29x | 19.50x | $72.97M | 12.51% | $256.55M | 1.74 | $438.68M | 5.52 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.